Samsung wins ITC ban on Apple products

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Samsung wins ITC ban on Apple products

The ITC has banned imports and sales of several older iPhone and iPad models sold by AT&T after finding Apple infringed a patent owned by Samsung

On Tuesday, the ITC issued a limited order preventing sales and imports of AT&T models of the iPhone 4, iPhone 3GS, iPad 3G and iPad 2 3G. Samsung had also accused Apple of violating another three patents, but the ITC ruled that the Silicon Valley company did not infringe those.

The ITC ruled that Apple had infringed a standard essential patent covering 3G wireless technology.

The ruling reversed a September decision by ITC Judge James Gildea, who found that Apple did not infringe the patents. The case, 337-794, was filed in August 2011.

The case is the latest instalment in a long-running battle between the two companies over smartphone technology.

"We are disappointed that the commission has overturned an earlier ruling and we plan to appeal. Today’s decision has no impact on the availability of Apple products in the United States," Apple spokeswoman Kristin Huguet said in a statement.

Samsung issued a statement which said the ITC decision “confirmed Apple’s history of free-riding on Samsung’s technological innovations”.

“Our decades of research and development in mobile technologies will continue and we will continue to offer innovative products to consumers in the United States,” it read.

Apple has filed a separate ITC complaint, accusing Samsung of infringing two patents relating to its iPhone and iPad devices. An ITC judge ruled that Samsung infringed one patent but not the other. A final ruling on that case is expected in August.

more from across site and SHARED ros bottom lb

More from across our site

In-house counsel explain why firms should provide risk management advice that helps them achieve their goals
Attorneys at four firms explain the AI trends they expect in the future, including a potential shift in who plaintiffs sue for copyright infringement
The dispute at the Intellectual Property Enterprise Court pits Dryrobe against D-Robe and will include a ‘genericide’ element
Novo Nordisk losing patent rights covering Ozempic in Canada and a US Supreme Court decision favouring Ed Sheeran were also among the top talking points
The court will hand down its ruling in Iconix v Dream Pairs on Tuesday, June 24, in a case that concerns post-sale confusion
Developments included a stay in a row concerning the UPC’s jurisdiction and a timeline for the rollout of the long-awaited new CMS
Jorg Thomaier, who has been head of IP at the German pharma company since 2010, will leave later this year and hand the reins to the company’s head of patents
Companies must conduct thorough IP due diligence – even if it may not be mandatory
Celia Cheah at Wong & Partners in Malaysia says she is aiming to tap into the Baker McKenzie member firm’s international network and expand its IP portfolio
A team of partners that joined Boies Schiller Flexner say they would like to double the firm’s patent litigation capabilities
Gift this article